The forecasted sold production of antisera and vaccines in Spain shows a consistent upward trend from 2024 to 2028, starting at 794.28 million euros in 2024 and reaching 890.34 million euros by 2028. This reflects a year-on-year percentage increase of 3.07% from 2024 to 2025, 2.95% from 2025 to 2026, 2.83% from 2026 to 2027, and 2.73% from 2027 to 2028. Over the last five years, the compound annual growth rate (CAGR) is 2.89%, indicating steady growth in the industry.
Looking forward, it is crucial to monitor:
- Regulatory changes impacting production and distribution
- Advancements in biotechnologies and vaccine developments
- Market demand influenced by global health issues and vaccination programs
- Competitive landscape with emerging players and innovations
